Logo
C

CALVIRI

14 employees

Calviri provides cancer treatment products by combining the immunogenic source of neoantigens with a peptide array platform.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Veterinary
cancervaccines
Vaccines
research
Peptides
Oncology
Science
cancer vaccines
early cancer detection
Prophylactic
Diagnostics
Arrays
Healthcare
Calviri
ICI diagnostic
Biotech
Health Diagnostics
Marc Wolff
dog trial
Stephen Albert Johnston
Therapeutics
Neoantigens
Prevention
Therapeutic
Startup

Date founded

2018

FAQ